Professor Dennis Yue

AM
Emeritus Professor
Medicine, Central Clinical School

Telephone +61 2 9515 5888
Fax +61 2 9516 1273

Map

Selected grants

2011

  • Preventing Adverse Effects of Matrix Metalloproteinases in Diabetic Wound Healing; McLennan S, Twigg S, Min D, Yue D; National Health and Medical Research Council (NHMRC)/Project Grants.

2009

  • Funded Position; Yue D, McLennan S; Sydney South West Area Health Service/Research Support.

2007

  • Rotor-Gene 6000, 5-Plex HRM with desktop computer & Gene-Disc 100 Stater Kit; Halliday G, Yue D, Sharland A, Bishop A, Stocker R, Bao B, McLennan S, Matsumoto I, Hambly B, Rose B, Harbour C, Ho J, Lee C, Twigg S, Soon L, Richardson D, King N, Zreiqat H; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2005

  • Role of circulating advanced glycation end products (AGEs) in diabetic nephropathy: effect of benfotiamine intervention; Yue D, Jerums G; National Health and Medical Research Council (NHMRC)/Project Grants.

2004

  • Diabetes Centre Fund; Yue D, Head-of C, Head-of M; Diabetes Centre/Research Grants.
  • Diabetes Research; Yue D; Diabetes Centre/Research Grants.

2003

  • Type I diabetes in baboons: The effects of inhibiting advanced glycation on diabetic complications; Yue D, McLennan S; Rebecca L Cooper/Medical Research Foundation.
  • 2 x leica microsystems imaging systems; 2 x Computer workstations; Black J, Pollard J, Yue D, McLennan S, Twigg S; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2002

  • Type I diabetes in baboons: the effects of inhibiting advanced glycation on diabetic complications; Yue D, McLennan S; Juvenile Diabetes Fdn Internat/Research Grant.

2001

  • Endocrinology Research; Yue D; Medicine Research/Medicine Grant Scheme.
  • Insulin dependent baboons : a model for the study of early complications of diabetes; Yue D; Rebecca L Cooper/Medical Research Foundation.
  • Establishing a causal relationship between advanced glycation and diabetic complications: studies using a primate model of Type 1 diabetes; Yue D; Diabetes Australia Research Trust/Awards and Research Grants.

2000

  • Free mixtures of insulin lispro protamine suspension and lispro insulin: Comparison; Yue D; Eli Lilly Australia Pty Limited/Project Support.
  • Impaired mesangium degradation in diabetic nephropathy: mesangial cell and primate studies; Yue D; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Irbesartan; Yue D; Bristol Myers Squibb/Contract Research.
  • The psychobiology of energy balance; Green J, Yue D; Australian Research Council (ARC)/Small Grants.
  • Membrane type metalloproteinase:its role in decreased metalloproteinase activities in diabetic nephropathy; Yue D; Juvenile Diabetes Research Foundation International (JDRF)/Research Grant.
  • Insulin dependent diabetic baboons: a model for the study of early complications of diabetes; Yue D; Rebecca L Cooper Medical Research Foundation/Grants Program.
  • Insulin dependent diabetic baboons: a model for the study of early complications of diabetes; Yue D; Rebecca L Cooper/Medical Research Foundation.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Overland, J., McGill, M., Yue, D. (2010). The Role of Community and Specialist Services. In Richard I.G. Holt, Clive S. Cockram, Allan Flyvbjerg, Barry J. Goldstein (Eds.), International Textbook of Diabetes Mellitus:4th Edition. United Kingdom: Wiley-Blackwell Publishing.
  • Yue, D., McGill, M. (2009). Insulin Therapy. In Alan J. Sinclair (Eds.), Diabetes in Old Age, (pp. 265-272). United Kingdom: John Wiley & Sons.

Journals

  • Zhang, X., Brooks, B., Molyneaux, L., Landy, E., Banatwalla, R., Wu, T., Wong, J., Su, B., Yue, D. (2014). Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity. International Journal of Endocrinology, 2014, 1-5. [More Information]
  • Yale, J., Bakris, G., Cariou, B., Yue, D., David Neto, E., Xi, L., Figueroa, K., Wajs, E., Usiskin, K., Meininger, G. (2013). Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Diabetes, Obesity and Metabolism, 15(5), 463-473. [More Information]
  • Leader, N., Ryan, L., Molyneaux, L., Yue, D. (2013). How best to use partial meal replacement in managing overweight or obese patients with poorly controlled type 2 diabetes. Obesity, 21(2), 251-253. [More Information]
  • Liu, Y., Brooks, B., McCosker, S., Molyneaux, L., Yue, D. (2013). How do we distinguish loss of vibration sensation due to neuropathy from that due to ageing? Practical Diabetes, 30(5), 186-188. [More Information]
  • Constantino, M., Molyneaux, L., Limacher-Gisler, F., Al-Saaed, A., Luo, C., Wu, T., Twigg, S., Yue, D., Wong, J. (2013). Long-Term Complications and Mortality in Young-Onset Diabetes: Type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care, 36(12), 3863-3869. [More Information]
  • Min, D., Brooks, B., Wong, J., Salomon, R., Bao, W., Harrisberg, B., Twigg, S., Yue, D., McLennan, S. (2012). Alterations in Monocyte CD16 in Association with Diabetes Complications. Mediators of Inflammation, 2012, 1-10. [More Information]
  • Chakera, A., Carleton, V., Ellard, S., Wong, J., Yue, D., Pinner, J., Hattersley, A., Ross, G. (2012). Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care, 35(9), 1832-1834. [More Information]
  • Simmons, L., Molyneaux, L., Yue, D., Chua, E. (2012). Steroid-Induced Diabetes: Is It Just Unmasking of Type 2 Diabetes? ISRN Endocrinology, 2012, 1-5. [More Information]
  • Pertot, T., Molyneaux, L., Tan, K., Ross, G., Yue, D., Wong, J. (2011). Can Common Clinical Parameters be used to Identify Patients Who Will Need Insulin Treatment in Gestational Diabetes Mellitus? Diabetes Care, 34(10), 2214-2216. [More Information]
  • Lo, L., McLennan, S., Williams, P., Bonner, J., Chowdhury, S., McCaughan, G., Gorrell, M., Yue, D., Twigg, S. (2011). Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. Journal of Hepatology, 55(2), 435-444. [More Information]
  • Perera, N., Molyneaux, L., Constantino, M., McGill, M., Yue, D., Twigg, S., Ross, G. (2011). Suboptimal Performance of Blood Glucose Meters in an Antenatal Diabetes Clinic. Diabetes Care, 34(2), 335-337. [More Information]
  • Perera, N., Stewart, P., Williams, P., Chua, E., Yue, D., Twigg, S. (2011). The danger of using inappropriate point-of-care glucose meters in patients on icodextrin dialysis. Diabetic Medicine, 28(10), 1272-1276. [More Information]
  • Perera, N., Harding, A., Constantino, M., Molyneaux, L., McGill, M., Chua, E., Twigg, S., Ross, G., Yue, D. (2011). Triple-B (basal-bolus-booster) subcutaneous insulin regimen: A pragmatic approach to managing hospital inpatient hyperglycaemia. Practical Diabetes, 28(6), 266-269. [More Information]
  • Thomson, S., McLennan, S., Hennessy, A., Boughton, P., Bonner, J., Zoellner, H., Yue, D., Twigg, S. (2010). A novel primate model of delayed wound healing in diabetes: dysregulation of connective tissue growth factor. Diabetologia, 53, 572-583. [More Information]
  • Wong, J., Molyneaux, L., Constantino, M., Twigg, S., Yue, D. (2010). Beyond ONTARGET: Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockade in Combination, a Lesser Evil in Some? Diabetes, Obesity and Metabolism, 12(12), 1072-1078. [More Information]
  • Bao, W., Min, D., Twigg, S., Shackel, N., Warner, F., Yue, D., McLennan, S. (2010). Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications. American Journal of Physiology: Cell Physiology, 299(5), C1212-C1219. [More Information]
  • Ban, C., Twigg, S., Franjic, B., Brooks, B., Celermajer, D., Yue, D., McLennan, S. (2010). Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction. Diabetes Research and Clinical Practice, 87(3), 335-341. [More Information]
  • Luo, C., Wong, J., Brown, M., Hooper, M., Molyneaux, L., Yue, D. (2009). Hypovitaminosis D in Chinese type 2 diabetes: lack of impact on clinical metabolic status and biomarkers of cellular inflammation. Diabetes and Vascular Disease Research, 6(3), 194-199. [More Information]
  • Liu, Y., Min, D., Bolton, T., Nube, V., Twigg, S., Yue, D., McLennan, S. (2009). Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers. Diabetes Care, 32(1), 117-119. [More Information]
  • Overland, J., Molyneaux, L., Tewari, S., Fatouros, P., Melville, P., Foote, D., Wu, T., Yue, D. (2009). Lipohypertrophy: does it matter in daily life? A study using a continuous glucose monitoring system. Diabetes, Obesity and Metabolism, 11(5), 460-463. [More Information]
  • Min, D., Lyons, G., Bonner, J., Twigg, S., Yue, D., McLennan, S. (2009). Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. American Journal of Physiology: Renal Physiology (Print), 297(5), F1229-F1237. [More Information]
  • Wong, J., McLennan, S., Molyneaux, L., Min, D., Twigg, S., Yue, D. (2009). Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications. Diabetologia, 52, 1953-1961. [More Information]
  • Cheung, N., Yue, D., Kotowicz, M., Jones, P., Flack, J. (2008). A comparison of diabetes clinics with different emphasis on routine care, complications assessment and shared care. Diabetic Medicine, 25(8), 974-978. [More Information]
  • Wong, J., Nock, N., Xu, Z., Kyle, C., Daniels, A., White, M., Yue, D., Elston, R., Mountjoy, K. (2008). A polymorphism (D20S32e) close to the human melanocortin receptor 3 is associated with insulin resistance but not the metabolic syndrome. Diabetes Research and Clinical Practice, 80(2), 203-207. [More Information]
  • Brooks, B., McLennan, S., Twigg, S., Yue, D. (2008). Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications. Diabetes and Vascular Disease Research, 5(1), 30-35. [More Information]
  • Sorensen, L., Siddall, P., Trenell, M., Yue, D. (2008). Differences in Metabolites in Pain-Processing Brain Regions in Patients With Diabetes and Painful Neuropathy. Diabetes Care, 31(5), 980-981. [More Information]
  • Wong, J., Molyneaux, L., Zhao, D., Constantino, M., Gray, R., Twigg, S., Xu, Z., Yue, D. (2008). Different accelerators to early-onset Type 2 diabetes: a comparison of Anglo-Celtic and Chinese patients. Journal of Diabetes and Its Complications, 22(6), 389-394. [More Information]
  • Brooks, B., Delaney-Robinson, C., Molyneaux, L., Yue, D. (2008). Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C β inhibitor, ruboxistaurin. Journal of Diabetes and Its Complications, 22(2), 88-95. [More Information]
  • Thomson, S., McLennan, S., Kirwan, P., Heffernan, S., Hennessy, A., Yue, D., Twigg, S. (2008). Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. Journal of Diabetes and Its Complications, 22(4), 284-294. [More Information]
  • McLennan, S., Bonner, J., Milne, S., Lo, L., Charlton, A., Kurup, S., Jia, J., Yue, D., Twigg, S. (2008). The anti-inflammatory agent Propolis improves wound healing in a rodent model of experimental diabetes. Wound Repair and Regeneration, 16, 706-713. [More Information]
  • Brooks, B., Heffernan, S., Thomson, S., McLennan, S., Twigg, S., Yue, D. (2008). The Effects of Diabetes and Aminoguanidine Treatment on Endothelial Function in a Primate Model of Type 1 Diabetes. American Journal of Primatology, 70(8), 796-802. [More Information]
  • Jiang, L., Wang, A., Molyneaux, L., Constantino, M., Yue, D. (2008). The long-term impact of ferritin level on treatment and complications of type 2 diabetes. Diabetes, Obesity and Metabolism, 10(6), 519-522. [More Information]
  • McGill, M., Molyneaux, L., Twigg, S., Yue, D. (2008). The metabolic syndrome in type 1 diabetes: does it exist and does it matter? Journal of Diabetes and Its Complications, 22(1), 18-23. [More Information]
  • Wong, J., Twigg, S., Molyneaux, L., Yue, D., Constantino, M. (2008). Timing is Everything: Age of Onset Influences Long-Term Retinopathy Risk in Type 2 Diabetes, Independent of Traditional Risk Factors. Diabetes Care, 31(10), 1985-1990. [More Information]
  • McLennan, S., Kelly, D., Schache, M., Waltham, M., Dy, V., Langham, R., Yue, D., Gilbert, R. (2007). Advanced glycation end products decrease mesangial cell MMP-7: A role in matrix accumulation in diabetic nephropathy? Kidney International, 72(4), 481-488. [More Information]
  • Xu, L., McLennan, S., Lo, L., Natfaji, A., Bolton, T., Liu, Y., Twigg, S., Yue, D. (2007). Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care, 30(2), 378-380. [More Information]
  • Brooks, B., Franjic, B., Ban, C., Swaraj, K., Yue, D., Celermajer, D., Twigg, S. (2007). Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes, Obesity and Metabolism, online publication(doi: 10.1111/j.1463-1326.2007.00803.x), 1-8. [More Information]
  • McLennan, S., McGill, M., Twigg, S., Yue, D. (2007). Improving wound-healing outcomes in diabetic foot ulcers. Expert Review of Endocrinology & Metabolism, 2, 205-213.
  • McElduff, A., Yue, D. (2007). Inhaled insulin: where are we and where might we go? Medical Journal of Australia, 186, 390-391. [More Information]
  • Nube, V., Bolton, T., Chua, E., Yue, D. (2007). Osteomyelitis in the Diabetic Foot: What Lies Beneath. Primary Intention, 15(2), 49-57.
  • Nube, V., Molyneaux, L., Yue, D. (2006). Biomechanical risk factors associated with neuropathic ulceration of the hallux in people with diabetes mellitus. Journal of the American Podiatric Medical Association, 96(3), 189-197. [More Information]
  • Ong, C., Molyneaux, L., Constantino, M., Twigg, S., Yue, D. (2006). Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes. Diabetes Care, 29(11), 2361-2364. [More Information]
  • Sorensen, L., Molyneaux, L., Yue, D. (2006). The level of small nerve fiber dysfunction does not predict pain in diabetic Neuropathy: a study using quantitative sensory testing. Clinical Journal of Pain, 22(3), 261-265. [More Information]
  • Molyneaux, L., Twigg, S., Yue, D., Constantino, M., Wong, J. (2006). The metabolic syndrome in type 2 diabetes: When does it matter? Diabetes, Obesity and Metabolism, 8(6), 690-697. [More Information]
  • Sorensen, L., Molyneaux, L., Yue, D. (2006). The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care, 29(4), 883-887. [More Information]
  • Fulcher, G., Gilbert, R., Yue, D. (2005). Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy. Internal Medicine Journal, 35(9), 536-542. [More Information]
  • Skilton, M., Lai, N., Griffiths, K., Molyneaux, L., Yue, D., Sullivan, D., Celermajer, D. (2005). Meal-related increases in vascular reactivity are impaired in older and diabetic adults: insights into roles of aging and insulin in vascular flow. American Journal of Physiology: Heart and Circulatory Physiology, 288(3), H1404-H1410. [More Information]
  • McGill, M., Molyneaux, L., Yue, D. (2005). Which diabetic patients should receive podiatry care? An objective analysis. Internal Medicine Journal, 35(8), 451-456. [More Information]
  • Thomas, M., MacIsaac, R., Tsalamandris, C., Molyneaux, L., Goubina, I., Fulcher, G., Yue, D., Jerums, G. (2004). Anemia In Patients With Type 1 Diabetes. Journal of Clinical Endocrinology and Metabolism, 89(9), 4359-4363.
  • McLennan, S., Wang, X., Moreno, V., Yue, D., Twigg, S. (2004). Connective Tissue Growth Factor Mediates High Glucose Effects On Matrix Degradation Through Tissue Inhibitor Of Matrix Metalloproteinase Type 1: Implications For Diabetic Nephropathy. Endocrinology, 145(12), 5646-5655.
  • Molyneaux, L., Constantino, M., Yue, D. (2004). Strong Family History Predicts A Younger Age Of Onset For Subjects Diagnosed With Type 2 Diabetes. Diabetes, Obesity and Metabolism, 6(3), 187-194.
  • Thomas, M., MacIsaac, R., Tsalamandris, C., Molyneaux, L., Goubina, I., Fulcher, G., Yue, D., Jerums, G. (2004). The Burden Of Anaemia In Type 2 Diabetes And The Role Of Nephropathy: A Cross-Sectional Audit. Nephrology, Dialysis, Transplantation, 19(7), 1792-1797.
  • Heather, A., Fisher, E., McGrath, K., Yue, D. (2003). High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis, 168(2), 263-269.
  • McLennan, S., Kelly, D., Cox, A., Cao, Z., Lyons, G., Yue, D., Gilbert, R. (2002). Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia, 45, 268-275. [More Information]
  • McLennan, S., Martell, S., Yue, D. (2002). Effects of mesangnium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy. Diabetes, 51(8), 2612-2618.
  • Nube, V., Yue, D., McGill, M., Molyneaux, L. (2002). From acute to chronic: monitoring the progress of Charcot's arthropathy. Journal of the American Podiatric Medical Association, 92(7), 384-389.
  • Sorensen, L., Yue, D., Molyneaux, L. (2002). Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control. Diabetes Research and Clinical Practice, 57(1), 45-51.
  • Heather, A., Nakhla, S., McGrath, K., Martell, S., Yue, D., Celermajer, D., Jessup, W. (2002). Nitroglycerin upregulates matrix metalloproteinase expression by human macrophages. Journal of the American College of Cardiology, 39(12), 1943-1950.
  • Liu, D., Molyneaux, L., Chua, E., Wang, Y., Wu, C., Jing, H., Hu, L., Liu,, Y., Xu, Z., Yue, D. (2002). Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Research and Clinical Practice, 56(2), 125-131.
  • Overland, J., Hayes, L., Yue, D. (2002). Social disadvantage: Its impact on the use of Medicare services related to diabetes in NSW. Australian and New Zealand Journal of Public Health, 26(3), 262-265.
  • Birrell, A., Heffernan, S., Kirwan, P., McLennan, S., Gillin, A., Yue, D. (2002). The effects of aminoguanidine on renal changes in a baboon model of type 1 diabetes. Journal of Diabetes and Its Complications, 16(4), 301-309.
  • Premawardhana, U., Adams, M., Yue, D., Celermajer, D., Birrell, A. (2001). Cardiovascular structure and function in baboons with Type 1 diabetes - a transvenous ultrasound study. Journal of Diabetes and Its Complications, 15, 174-180.
  • Overland, J., Yue, D., Mira, M. (2001). Continuity of care in diabetes: to whom does it matter? Diabetes Research and Clinical Practice, 52, 55-61.
  • Overland, J., Mira, M., Yue, D. (2001). Diffential shared care for diabetes: does it provide the optimal partition between primary and specialist care? Diabetic Medicine, 18, 554-557.
  • Brooks, B., Yue, D., Dean, R., Patel, S., Wu, B., Molyneaux, L. (2001). TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabetic Medicine, 18, 528-532.
  • Overland, J., Yue, D., Mira, M. (2001). Use of Medicare services related to diabetes care: the impact of rural isolation. Australian Journal of Rural Health, 9, 311-316.
  • Birrell, A., Heffernan, S., Ansselin, A., McLennan, S., Church, D., Gillin, A., Yue, D. (2000). Functional and structural abnormalities in the nerves of Type 1 diabetic baboons: aminoguanidine treatment does not improve nerve function. Diabetologia, 43, 110-116.
  • Overland, J., Yue, D., Mira, M. (2000). The pattern of diabetes care in New South Wales: a five-year analysis using Medicare occasions of service data. Australian and New Zealand Journal of Public Health, 24, 391-395.

Conferences

  • Thomson, S., McLennan, S., Hennessy, A., Bonner, J., Zoellner, H., Yue, D., Twigg, S. (2007). Dysregulated inflammation predicts reduced connective tissue growth factor expression in a baboon wound healing model of type 1 diabetes. The 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), Germany: Springer-Verlag.
  • McLennan, S., Jia, J., Milne, S., Lo, L., Bonner, J., Yue, D., Twigg, S. (2006). Propolis, the anti-inflammatory bee hive protectant improves wound healing in experimental diabetes. 42nd Annual Meeting of the European Association for the Study of Diabetes (EASD), Germany: Springer-Verlag.
  • Li, J., Yang, G., Yue, D. (2005). Investing in China: A network perspective on the diffusion of FDI entry decision across countries. Academy of Management Annual Meeting 2005, Glassboro, NJ, USA: Academy of Management.
  • Overland, J., Yue, D., Mira, M. (2001). The use of Medicare services related to diabetes: The impact of rural isolation. ADS & ADEA Annual Scientific Meeting, : Ads & Adea.

2014

  • Zhang, X., Brooks, B., Molyneaux, L., Landy, E., Banatwalla, R., Wu, T., Wong, J., Su, B., Yue, D. (2014). Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity. International Journal of Endocrinology, 2014, 1-5. [More Information]

2013

  • Yale, J., Bakris, G., Cariou, B., Yue, D., David Neto, E., Xi, L., Figueroa, K., Wajs, E., Usiskin, K., Meininger, G. (2013). Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Diabetes, Obesity and Metabolism, 15(5), 463-473. [More Information]
  • Leader, N., Ryan, L., Molyneaux, L., Yue, D. (2013). How best to use partial meal replacement in managing overweight or obese patients with poorly controlled type 2 diabetes. Obesity, 21(2), 251-253. [More Information]
  • Liu, Y., Brooks, B., McCosker, S., Molyneaux, L., Yue, D. (2013). How do we distinguish loss of vibration sensation due to neuropathy from that due to ageing? Practical Diabetes, 30(5), 186-188. [More Information]
  • Constantino, M., Molyneaux, L., Limacher-Gisler, F., Al-Saaed, A., Luo, C., Wu, T., Twigg, S., Yue, D., Wong, J. (2013). Long-Term Complications and Mortality in Young-Onset Diabetes: Type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care, 36(12), 3863-3869. [More Information]

2012

  • Min, D., Brooks, B., Wong, J., Salomon, R., Bao, W., Harrisberg, B., Twigg, S., Yue, D., McLennan, S. (2012). Alterations in Monocyte CD16 in Association with Diabetes Complications. Mediators of Inflammation, 2012, 1-10. [More Information]
  • Chakera, A., Carleton, V., Ellard, S., Wong, J., Yue, D., Pinner, J., Hattersley, A., Ross, G. (2012). Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care, 35(9), 1832-1834. [More Information]
  • Simmons, L., Molyneaux, L., Yue, D., Chua, E. (2012). Steroid-Induced Diabetes: Is It Just Unmasking of Type 2 Diabetes? ISRN Endocrinology, 2012, 1-5. [More Information]

2011

  • Pertot, T., Molyneaux, L., Tan, K., Ross, G., Yue, D., Wong, J. (2011). Can Common Clinical Parameters be used to Identify Patients Who Will Need Insulin Treatment in Gestational Diabetes Mellitus? Diabetes Care, 34(10), 2214-2216. [More Information]
  • Lo, L., McLennan, S., Williams, P., Bonner, J., Chowdhury, S., McCaughan, G., Gorrell, M., Yue, D., Twigg, S. (2011). Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. Journal of Hepatology, 55(2), 435-444. [More Information]
  • Perera, N., Molyneaux, L., Constantino, M., McGill, M., Yue, D., Twigg, S., Ross, G. (2011). Suboptimal Performance of Blood Glucose Meters in an Antenatal Diabetes Clinic. Diabetes Care, 34(2), 335-337. [More Information]
  • Perera, N., Stewart, P., Williams, P., Chua, E., Yue, D., Twigg, S. (2011). The danger of using inappropriate point-of-care glucose meters in patients on icodextrin dialysis. Diabetic Medicine, 28(10), 1272-1276. [More Information]
  • Perera, N., Harding, A., Constantino, M., Molyneaux, L., McGill, M., Chua, E., Twigg, S., Ross, G., Yue, D. (2011). Triple-B (basal-bolus-booster) subcutaneous insulin regimen: A pragmatic approach to managing hospital inpatient hyperglycaemia. Practical Diabetes, 28(6), 266-269. [More Information]

2010

  • Thomson, S., McLennan, S., Hennessy, A., Boughton, P., Bonner, J., Zoellner, H., Yue, D., Twigg, S. (2010). A novel primate model of delayed wound healing in diabetes: dysregulation of connective tissue growth factor. Diabetologia, 53, 572-583. [More Information]
  • Wong, J., Molyneaux, L., Constantino, M., Twigg, S., Yue, D. (2010). Beyond ONTARGET: Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockade in Combination, a Lesser Evil in Some? Diabetes, Obesity and Metabolism, 12(12), 1072-1078. [More Information]
  • Bao, W., Min, D., Twigg, S., Shackel, N., Warner, F., Yue, D., McLennan, S. (2010). Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications. American Journal of Physiology: Cell Physiology, 299(5), C1212-C1219. [More Information]
  • Ban, C., Twigg, S., Franjic, B., Brooks, B., Celermajer, D., Yue, D., McLennan, S. (2010). Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction. Diabetes Research and Clinical Practice, 87(3), 335-341. [More Information]
  • Overland, J., McGill, M., Yue, D. (2010). The Role of Community and Specialist Services. In Richard I.G. Holt, Clive S. Cockram, Allan Flyvbjerg, Barry J. Goldstein (Eds.), International Textbook of Diabetes Mellitus:4th Edition. United Kingdom: Wiley-Blackwell Publishing.

2009

  • Luo, C., Wong, J., Brown, M., Hooper, M., Molyneaux, L., Yue, D. (2009). Hypovitaminosis D in Chinese type 2 diabetes: lack of impact on clinical metabolic status and biomarkers of cellular inflammation. Diabetes and Vascular Disease Research, 6(3), 194-199. [More Information]
  • Liu, Y., Min, D., Bolton, T., Nube, V., Twigg, S., Yue, D., McLennan, S. (2009). Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers. Diabetes Care, 32(1), 117-119. [More Information]
  • Yue, D., McGill, M. (2009). Insulin Therapy. In Alan J. Sinclair (Eds.), Diabetes in Old Age, (pp. 265-272). United Kingdom: John Wiley & Sons.
  • Overland, J., Molyneaux, L., Tewari, S., Fatouros, P., Melville, P., Foote, D., Wu, T., Yue, D. (2009). Lipohypertrophy: does it matter in daily life? A study using a continuous glucose monitoring system. Diabetes, Obesity and Metabolism, 11(5), 460-463. [More Information]
  • Min, D., Lyons, G., Bonner, J., Twigg, S., Yue, D., McLennan, S. (2009). Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. American Journal of Physiology: Renal Physiology (Print), 297(5), F1229-F1237. [More Information]
  • Wong, J., McLennan, S., Molyneaux, L., Min, D., Twigg, S., Yue, D. (2009). Mitochondrial DNA content in peripheral blood monocytes: relationship with age of diabetes onsetand diabetic complications. Diabetologia, 52, 1953-1961. [More Information]

2008

  • Cheung, N., Yue, D., Kotowicz, M., Jones, P., Flack, J. (2008). A comparison of diabetes clinics with different emphasis on routine care, complications assessment and shared care. Diabetic Medicine, 25(8), 974-978. [More Information]
  • Wong, J., Nock, N., Xu, Z., Kyle, C., Daniels, A., White, M., Yue, D., Elston, R., Mountjoy, K. (2008). A polymorphism (D20S32e) close to the human melanocortin receptor 3 is associated with insulin resistance but not the metabolic syndrome. Diabetes Research and Clinical Practice, 80(2), 203-207. [More Information]
  • Brooks, B., McLennan, S., Twigg, S., Yue, D. (2008). Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications. Diabetes and Vascular Disease Research, 5(1), 30-35. [More Information]
  • Sorensen, L., Siddall, P., Trenell, M., Yue, D. (2008). Differences in Metabolites in Pain-Processing Brain Regions in Patients With Diabetes and Painful Neuropathy. Diabetes Care, 31(5), 980-981. [More Information]
  • Wong, J., Molyneaux, L., Zhao, D., Constantino, M., Gray, R., Twigg, S., Xu, Z., Yue, D. (2008). Different accelerators to early-onset Type 2 diabetes: a comparison of Anglo-Celtic and Chinese patients. Journal of Diabetes and Its Complications, 22(6), 389-394. [More Information]
  • Brooks, B., Delaney-Robinson, C., Molyneaux, L., Yue, D. (2008). Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C β inhibitor, ruboxistaurin. Journal of Diabetes and Its Complications, 22(2), 88-95. [More Information]
  • Thomson, S., McLennan, S., Kirwan, P., Heffernan, S., Hennessy, A., Yue, D., Twigg, S. (2008). Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy. Journal of Diabetes and Its Complications, 22(4), 284-294. [More Information]
  • McLennan, S., Bonner, J., Milne, S., Lo, L., Charlton, A., Kurup, S., Jia, J., Yue, D., Twigg, S. (2008). The anti-inflammatory agent Propolis improves wound healing in a rodent model of experimental diabetes. Wound Repair and Regeneration, 16, 706-713. [More Information]
  • Brooks, B., Heffernan, S., Thomson, S., McLennan, S., Twigg, S., Yue, D. (2008). The Effects of Diabetes and Aminoguanidine Treatment on Endothelial Function in a Primate Model of Type 1 Diabetes. American Journal of Primatology, 70(8), 796-802. [More Information]
  • Jiang, L., Wang, A., Molyneaux, L., Constantino, M., Yue, D. (2008). The long-term impact of ferritin level on treatment and complications of type 2 diabetes. Diabetes, Obesity and Metabolism, 10(6), 519-522. [More Information]
  • McGill, M., Molyneaux, L., Twigg, S., Yue, D. (2008). The metabolic syndrome in type 1 diabetes: does it exist and does it matter? Journal of Diabetes and Its Complications, 22(1), 18-23. [More Information]
  • Wong, J., Twigg, S., Molyneaux, L., Yue, D., Constantino, M. (2008). Timing is Everything: Age of Onset Influences Long-Term Retinopathy Risk in Type 2 Diabetes, Independent of Traditional Risk Factors. Diabetes Care, 31(10), 1985-1990. [More Information]

2007

  • McLennan, S., Kelly, D., Schache, M., Waltham, M., Dy, V., Langham, R., Yue, D., Gilbert, R. (2007). Advanced glycation end products decrease mesangial cell MMP-7: A role in matrix accumulation in diabetic nephropathy? Kidney International, 72(4), 481-488. [More Information]
  • Xu, L., McLennan, S., Lo, L., Natfaji, A., Bolton, T., Liu, Y., Twigg, S., Yue, D. (2007). Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care, 30(2), 378-380. [More Information]
  • Brooks, B., Franjic, B., Ban, C., Swaraj, K., Yue, D., Celermajer, D., Twigg, S. (2007). Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes, Obesity and Metabolism, online publication(doi: 10.1111/j.1463-1326.2007.00803.x), 1-8. [More Information]
  • Thomson, S., McLennan, S., Hennessy, A., Bonner, J., Zoellner, H., Yue, D., Twigg, S. (2007). Dysregulated inflammation predicts reduced connective tissue growth factor expression in a baboon wound healing model of type 1 diabetes. The 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), Germany: Springer-Verlag.
  • McLennan, S., McGill, M., Twigg, S., Yue, D. (2007). Improving wound-healing outcomes in diabetic foot ulcers. Expert Review of Endocrinology & Metabolism, 2, 205-213.
  • McElduff, A., Yue, D. (2007). Inhaled insulin: where are we and where might we go? Medical Journal of Australia, 186, 390-391. [More Information]
  • Nube, V., Bolton, T., Chua, E., Yue, D. (2007). Osteomyelitis in the Diabetic Foot: What Lies Beneath. Primary Intention, 15(2), 49-57.

2006

  • Nube, V., Molyneaux, L., Yue, D. (2006). Biomechanical risk factors associated with neuropathic ulceration of the hallux in people with diabetes mellitus. Journal of the American Podiatric Medical Association, 96(3), 189-197. [More Information]
  • Ong, C., Molyneaux, L., Constantino, M., Twigg, S., Yue, D. (2006). Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes. Diabetes Care, 29(11), 2361-2364. [More Information]
  • McLennan, S., Jia, J., Milne, S., Lo, L., Bonner, J., Yue, D., Twigg, S. (2006). Propolis, the anti-inflammatory bee hive protectant improves wound healing in experimental diabetes. 42nd Annual Meeting of the European Association for the Study of Diabetes (EASD), Germany: Springer-Verlag.
  • Sorensen, L., Molyneaux, L., Yue, D. (2006). The level of small nerve fiber dysfunction does not predict pain in diabetic Neuropathy: a study using quantitative sensory testing. Clinical Journal of Pain, 22(3), 261-265. [More Information]
  • Molyneaux, L., Twigg, S., Yue, D., Constantino, M., Wong, J. (2006). The metabolic syndrome in type 2 diabetes: When does it matter? Diabetes, Obesity and Metabolism, 8(6), 690-697. [More Information]
  • Sorensen, L., Molyneaux, L., Yue, D. (2006). The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care, 29(4), 883-887. [More Information]

2005

  • Fulcher, G., Gilbert, R., Yue, D. (2005). Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy. Internal Medicine Journal, 35(9), 536-542. [More Information]
  • Li, J., Yang, G., Yue, D. (2005). Investing in China: A network perspective on the diffusion of FDI entry decision across countries. Academy of Management Annual Meeting 2005, Glassboro, NJ, USA: Academy of Management.
  • Skilton, M., Lai, N., Griffiths, K., Molyneaux, L., Yue, D., Sullivan, D., Celermajer, D. (2005). Meal-related increases in vascular reactivity are impaired in older and diabetic adults: insights into roles of aging and insulin in vascular flow. American Journal of Physiology: Heart and Circulatory Physiology, 288(3), H1404-H1410. [More Information]
  • McGill, M., Molyneaux, L., Yue, D. (2005). Which diabetic patients should receive podiatry care? An objective analysis. Internal Medicine Journal, 35(8), 451-456. [More Information]

2004

  • Thomas, M., MacIsaac, R., Tsalamandris, C., Molyneaux, L., Goubina, I., Fulcher, G., Yue, D., Jerums, G. (2004). Anemia In Patients With Type 1 Diabetes. Journal of Clinical Endocrinology and Metabolism, 89(9), 4359-4363.
  • McLennan, S., Wang, X., Moreno, V., Yue, D., Twigg, S. (2004). Connective Tissue Growth Factor Mediates High Glucose Effects On Matrix Degradation Through Tissue Inhibitor Of Matrix Metalloproteinase Type 1: Implications For Diabetic Nephropathy. Endocrinology, 145(12), 5646-5655.
  • Molyneaux, L., Constantino, M., Yue, D. (2004). Strong Family History Predicts A Younger Age Of Onset For Subjects Diagnosed With Type 2 Diabetes. Diabetes, Obesity and Metabolism, 6(3), 187-194.
  • Thomas, M., MacIsaac, R., Tsalamandris, C., Molyneaux, L., Goubina, I., Fulcher, G., Yue, D., Jerums, G. (2004). The Burden Of Anaemia In Type 2 Diabetes And The Role Of Nephropathy: A Cross-Sectional Audit. Nephrology, Dialysis, Transplantation, 19(7), 1792-1797.

2003

  • Heather, A., Fisher, E., McGrath, K., Yue, D. (2003). High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis, 168(2), 263-269.

2002

  • McLennan, S., Kelly, D., Cox, A., Cao, Z., Lyons, G., Yue, D., Gilbert, R. (2002). Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia, 45, 268-275. [More Information]
  • McLennan, S., Martell, S., Yue, D. (2002). Effects of mesangnium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy. Diabetes, 51(8), 2612-2618.
  • Nube, V., Yue, D., McGill, M., Molyneaux, L. (2002). From acute to chronic: monitoring the progress of Charcot's arthropathy. Journal of the American Podiatric Medical Association, 92(7), 384-389.
  • Sorensen, L., Yue, D., Molyneaux, L. (2002). Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control. Diabetes Research and Clinical Practice, 57(1), 45-51.
  • Heather, A., Nakhla, S., McGrath, K., Martell, S., Yue, D., Celermajer, D., Jessup, W. (2002). Nitroglycerin upregulates matrix metalloproteinase expression by human macrophages. Journal of the American College of Cardiology, 39(12), 1943-1950.
  • Liu, D., Molyneaux, L., Chua, E., Wang, Y., Wu, C., Jing, H., Hu, L., Liu,, Y., Xu, Z., Yue, D. (2002). Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Research and Clinical Practice, 56(2), 125-131.
  • Overland, J., Hayes, L., Yue, D. (2002). Social disadvantage: Its impact on the use of Medicare services related to diabetes in NSW. Australian and New Zealand Journal of Public Health, 26(3), 262-265.
  • Birrell, A., Heffernan, S., Kirwan, P., McLennan, S., Gillin, A., Yue, D. (2002). The effects of aminoguanidine on renal changes in a baboon model of type 1 diabetes. Journal of Diabetes and Its Complications, 16(4), 301-309.

2001

  • Premawardhana, U., Adams, M., Yue, D., Celermajer, D., Birrell, A. (2001). Cardiovascular structure and function in baboons with Type 1 diabetes - a transvenous ultrasound study. Journal of Diabetes and Its Complications, 15, 174-180.
  • Overland, J., Yue, D., Mira, M. (2001). Continuity of care in diabetes: to whom does it matter? Diabetes Research and Clinical Practice, 52, 55-61.
  • Overland, J., Mira, M., Yue, D. (2001). Diffential shared care for diabetes: does it provide the optimal partition between primary and specialist care? Diabetic Medicine, 18, 554-557.
  • Brooks, B., Yue, D., Dean, R., Patel, S., Wu, B., Molyneaux, L. (2001). TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients? Diabetic Medicine, 18, 528-532.
  • Overland, J., Yue, D., Mira, M. (2001). The use of Medicare services related to diabetes: The impact of rural isolation. ADS & ADEA Annual Scientific Meeting, : Ads & Adea.
  • Overland, J., Yue, D., Mira, M. (2001). Use of Medicare services related to diabetes care: the impact of rural isolation. Australian Journal of Rural Health, 9, 311-316.

2000

  • Birrell, A., Heffernan, S., Ansselin, A., McLennan, S., Church, D., Gillin, A., Yue, D. (2000). Functional and structural abnormalities in the nerves of Type 1 diabetic baboons: aminoguanidine treatment does not improve nerve function. Diabetologia, 43, 110-116.
  • Overland, J., Yue, D., Mira, M. (2000). The pattern of diabetes care in New South Wales: a five-year analysis using Medicare occasions of service data. Australian and New Zealand Journal of Public Health, 24, 391-395.

To update your profile click here. For support on your academic profile contact .